Yahoo Finance Lannett Company First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags
Lannett Company (NYSE:LCI) First Quarter 2023 Results
Key Financial Results
Revenue: US$75.1m (down 26% from 1Q 2022).
Net loss: US$28.0m (loss widened by 25% from 1Q 2022).
US$0.68 loss per share (further deteriorated from US$0.56 loss in 1Q 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Lannett Company Revenues Beat Expectations, EPS Falls Short
Revenue exceeded analyst estimates by 10%. Earnings per share (EPS) missed analyst estimates by 51%.
Looking ahead, revenue is forecast to grow 5.2% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Pharmaceuticals industry in the US.
Performance of the American Pharmaceuticals industry.
The company's shares are up 8.8% from a week ago.
Risk Analysis
We should say that we've discovered 6 warning signs for Lannett Company (2 are a bit unpleasant!) that you should be aware of before investing here.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
